Skip to content

Reduction of Inappropriate psychotropic Drug use in nursing home residents with dementia. Dutch: Beter af met minder: Bewust gebruik van psychofarmaca.

Cluster randomized study on the effect of implementation of appropriate interventions at the department level to reduce inappropriate psychotropic drug use. RID: Reduction of Inappropriate psychotropic Drug use in nursing home residents with dementia.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26060
Enrollment
800
Registered
2016-05-27
Start date
2016-05-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inappropriate psychotropic drug use, neuropsychiatric symptoms and Quality of Life of nursing home residents with dementia. Onjuist psychofarmaca gebruik, neuropsychiatrische symptomen en kwaliteit van leven bij mensen met dementie in verpleeghuizen.

Interventions

The implementation of a facility tailored intervention: meaning that interventions vary depending on local problems of nursing homes in dealing with problem behavior. Possible interventions: systemati

Sponsors

Prof.dr. S.U.Zuidema, hoogleraar ouderengeneeskunde en dementie. Specialist Ouderengeneeskunde. s.u.zuidema@umcg.nl
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Person with dementia: diagnosis dementia (DSM-IV criteria), informed consent of legal representative.

Exclusion criteria

Exclusion criteria: Terminal patients (life expectancy < 3 months). Acquired brain injury departments, regular somatic departments, Down's syndrome and Korsakov.

Design outcomes

Primary

MeasureTime frame
Reduction of inappropriate psychotropic drugs (APID)

Secondary

MeasureTime frame
Quality of life (VAS + RISE) Problem behavior / neuro=psychiatric symptoms (NPI-NH + CMAI)

Contacts

Public ContactClaudia Groot Kormelinck
c.m.groot.kormelinck@umcg.nl06-55256735

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)